EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

DOI: 10.4143/crt.2018.125

Keywords: Non-squamous non-small cell lung cancer, Chemoradiotherapy, Stage III, EGFR mutation, Survival

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text